Thursday, March 02, 2017 5:06:53 PM
GW*H has a new inhaler type device, like the kind for certain asthma meds.
OWCP has the topical cream, sublingual tablet, and others.
GW*H will have the right delivery system for meds which you want in the blood system via the lungs, while OWCP will go topical and via the blood system via the mouth.
Different delivery systems for different indications.
Know What You Own. My posts should not be construed as investment advice.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM